meta_pixel
Tapesearch Logo
Log in
Nature Podcast

Coronapod: The rise of RNA vaccines

Nature Podcast

podcast@nature.com

News, Science, Technology

4.5893 Ratings

🗓️ 14 January 2021

⏱️ 22 minutes

🧾️ Download transcript

Summary

Benjamin Thompson, Noah Baker and Elie Dolgin discuss RNA vaccines.


In this episode:

 

01:16 How RNA vaccines came to prominence

In less than a year, two RNA vaccines against COVID-19 were designed, tested and rolled out across the world. We discuss these vaccines’ pros and cons, how RNA technology lends itself to rapid vaccine development, and what this means for the fight against other diseases.


News feature: How COVID unlocked the power of RNA vaccines


09:20 The hurdles for trialling new COVID-19 vaccines

Multiple candidates for new COVID-19 vaccines are still being developed, which may offer advantages over the vaccines currently available. However, running placebo-controlled trials of these candidates is becoming increasingly difficult, so researchers are looking for different ways to evaluate them.


News: Search for better COVID vaccines confounded by existing rollouts


14:45 How long will COVID vaccines be effective?

There is much concern around the world about two faster-spreading variants of SARS-CoV-2. We get an update on whether these variants could render vaccines ineffective.


News: Could new COVID variants undermine vaccines? Labs scramble to find out


Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.


Hosted on Acast. See acast.com/privacy for more information.

Transcript

Click on a timestamp to play from that location

0:00.0

Hello everyone. My name is Jamie Lang and I'm the host of Great Company podcast and today we are

0:04.7

very kindly sponsored by Sage. So as a business owner which you clearly are, there are tasks that need

0:10.1

doing right? Yeah, 100%. Well then, you're going to enjoy this advert. Sage's new AI productivity

0:16.4

assistant co-pilot can help you work faster, analyze how your business is performing and help

0:21.2

you make smarter decisions. Yes, Jemima, and it's powered by the latest innovations in Gen AI technology,

0:27.4

isn't it? Which means all those repetitive tasks I hate can be done so much quicker, more time

0:33.7

for scrolling on TikTok, obviously. And making TikToks. And making TikToks. Exactly.

0:39.1

Where do we visit, Jemima? Visit sage.com forward slash copilot to find out more.

0:44.4

This year, we've had a record 150,000 children homeless in England. We'll be waking up

0:50.9

homeless on Christmas morning, in cramped rooms, with nowhere to play,

0:55.3

and sometimes even having to share bathrooms with strangers.

1:00.0

This is not a home.

1:02.4

This is the heartbreaking reality, but it doesn't have to be this way.

1:07.0

Your donation to shelter could help a family find a safe place to call home.

1:12.1

Donate today at shelter.org.uk. Hi listeners, Benjamin here. It's our first Corona pod of the year and we have a lot

1:23.6

to discuss. So once again, we're putting the show out as a standalone podcast. Noah Baker is

1:30.1

here, of course, and making his CoronaPod debut is freelance reporter Ailey Dolgin. Hello to you

1:35.6

both. Hi, guys. Thanks for having me. Hi, Ben. Hi, Ailey. Indeed, an awful lot to talk about at beginning of

1:42.5

2021. I feel like we took a break over the holidays and

1:45.2

the world moved at a pace that I can barely keep up with and we have to try to catch up now.

1:51.4

Oh, definitely. But before we get into that, Ailey, you've written for Nature News many times and

1:56.3

you've appeared on the podcast a bunch over the years. But for people who aren't familiar with your voice,

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from podcast@nature.com, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of podcast@nature.com and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.